Seguir
Dr. Alexander Schulte
Dr. Alexander Schulte
Scientist
No hay ninguna dirección de correo electrónico verificada. - Página principal
Título
Citado por
Citado por
Año
The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10
S Abel, C Hundhausen, R Mentlein, A Schulte, TA Berkhout, N Broadway, ...
The Journal of Immunology 172 (10), 6362-6372, 2004
4552004
Hematogenous dissemination of glioblastoma multiforme
C Müller, J Holtschmidt, M Auer, E Heitzer, K Lamszus, A Schulte, ...
Science translational medicine 6 (247), 247ra101-247ra101, 2014
2672014
Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes
C Hundhausen, A Schulte, B Schulz, MG Andrzejewski, N Schwarz, ...
The Journal of Immunology 178 (12), 8064-8072, 2007
1982007
Engineering NK cells modified with an EGFRvIII-specific chimeric antigen receptor to overexpress CXCR4 improves immunotherapy of CXCL12/SDF-1α-secreting glioblastoma
N Müller, S Michen, S Tietze, K Töpfer, A Schulte, K Lamszus, M Schmitz, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 38 (5), 197, 2015
1602015
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells
A Ludwig, A Schulte, C Schnack, C Hundhausen, K Reiss, N Brodway, ...
Journal of neurochemistry 93 (5), 1293-1303, 2005
1412005
Hypoxia and oxygenation induce a metabolic switch between pentose phosphate pathway and glycolysis in glioma stem-like cells
A Kathagen, A Schulte, G Balcke, HS Phillips, T Martens, J Matschke, ...
Acta neuropathologica 126 (5), 763-780, 2013
1142013
A distinct subset of glioma cell lines with stem cell‐like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target
A Schulte, HS Günther, HS Phillips, D Kemming, T Martens, S Kharbanda, ...
Glia 59 (4), 590-602, 2011
1132011
Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab
M Voigt, F Braig, M Göthel, A Schulte, K Lamszus, C Bokemeyer, M Binder
Neoplasia 14 (11), 1023-IN3, 2012
1112012
Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation
A Kathagen-Buhmann, A Schulte, J Weller, M Holz, C Herold-Mende, ...
Neuro-oncology 18 (9), 1219-1229, 2016
1092016
A novel fluorescent pH probe for expression in plants
A Schulte, I Lorenzen, M Böttcher, C Plieth
Plant methods 2 (1), 1-13, 2006
1022006
Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by α-and γ-secretases
A Schulte, B Schulz, MG Andrzejewski, C Hundhausen, S Mletzko, ...
Biochemical and biophysical research communications 358 (1), 233-240, 2007
992007
Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin
F Scholz, A Schulte, F Adamski, C Hundhausen, J Mittag, A Schwarz, ...
Journal of Investigative Dermatology 127 (6), 1444-1455, 2007
842007
Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ
A Schulte, K Liffers, A Kathagen, S Riethdorf, S Zapf, A Merlo, K Kolbe, ...
Neuro-oncology 15 (10), 1289-1301, 2013
792013
Glioblastoma Stem–like Cell Lines with Either Maintenance or Loss of High-Level EGFR Amplification, Generated via Modulation of Ligand ConcentrationEGFR Amplification in Glioma …
A Schulte, HS Günther, T Martens, S Zapf, S Riethdorf, C Wülfing, ...
Clinical Cancer Research 18 (7), 1901-1913, 2012
742012
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
BM Braig F, März M, Schieferdecker A, Schulte A, Voigt M, Stein A, Grob T ...
Oncotarget 6 (14), 2015
602015
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
F Braig, M März, A Schieferdecker, A Schulte, M Voigt, A Stein, T Grob, ...
Oncotarget, 2015
602015
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies
M Preukschas, C Hagel, A Schulte, K Weber, K Lamszus, H Sievert, ...
Public Library of Science 7 (8), e43468, 2012
542012
EGFR amplification and glioblastoma stem-like cells
K Liffers, K Lamszus, A Schulte, A Schulte
Stem Cells International, 2015
512015
RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant
C Eckerich, A Schulte, T Martens, S Zapf, M Westphal, K Lamszus
Journal of neurochemistry 109 (4), 969-980, 2009
502009
Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
K Liffer, K Kolbe, M Westphal, K Lamszus, A Schulte
Targeted Oncology, 2015
382015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20